Why GYRE? Gyre Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
GYRE
$7.80+0.12 (+1.56%)
Market ClosedLast close May 1
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.